Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemiaCIMINO, G; ANNINO, L; GIONA, F et al.CIMINO, G; Leukemia. 1991, Vol 5, Num 7, pp 602-605, issn 0887-6924Article

Treatment update for AIDS-related Kaposi's sarcomaMIHALCEA, A. M; SMITH, D. L; MONINI, P et al.AIDS (Supplement). 1999, Vol 13, Num A, pp S215-S225, issn 1350-2840Article

Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10SGADARI, C; ANGIOLILLO, A. L; TOSATO, G et al.Blood. 1996, Vol 87, Num 9, pp 3877-3882, issn 0006-4971Article

Biology of Kaposi's sarcomaENSOLI, B; SGADARI, C; BARILLARI, G et al.European journal of cancer (1990). 2001, Vol 37, Num 10, pp 1251-1269, issn 0959-8049Article

SIngle daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignanciesMARTINO, P; GIRMENIA, C; RACCAH, R et al.Oncology. 1992, Vol 49, Num 1, pp 49-52, issn 0030-2414Article

The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5β1 and αvβ3 integrins and by mobilizing sequestered basic fibroblast growth factorBARILLARI, G; SGADARI, C; ENSOLI, B et al.Blood. 1999, Vol 94, Num 2, pp 663-672, issn 0006-4971Article

Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cellsTOSATO, G; SGADARI, C; TAGA, K et al.Blood. 1994, Vol 83, Num 3, pp 776-784, issn 0006-4971Article

Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsCIMINO, G; ANMADORI, S; CAVA, M. C et al.CIMINO, G; Leukemia. 1991, Vol 5, Num 1, pp 32-35, issn 0887-6924, 4 p.Article

Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapyCOCO, F. L; LOPEZ, M; PASQUALETTI, D et al.Hematological oncology. 1989, Vol 7, Num 2, pp 167-174, issn 0278-0232Article

Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12LEI YAO; SGADARI, C; FURUKE, K et al.Blood. 1999, Vol 93, Num 5, pp 1612-1621, issn 0006-4971Article

Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivoCHERNEY, B. W; SGADARI, C; KANEGANE, C et al.Blood. 1998, Vol 91, Num 7, pp 2491-2500, issn 0006-4971Article

Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cellsCHERNEY, B. W; BHATIA, K. G; SGADARI, C et al.Cancer research (Baltimore). 1997, Vol 57, Num 12, pp 2508-2515, issn 0008-5472Article

Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcomaMONINI, P; COLOMBINI, S; LEONE, Pasqualina et al.Blood. 1999, Vol 93, Num 12, pp 4044-4058, issn 0006-4971Article

Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivoSGADARI, C; FARBER, J. M; ANGIOLILLO, A. L et al.Blood. 1997, Vol 89, Num 8, pp 2635-2643, issn 0006-4971Article

Epstein-Barr virus as an agent of haematological diseaseTOSATO, G; TAGA, K; ANGIOLILLO, A. L et al.Baillière's clinical haematology. 1995, Vol 8, Num 1, pp 165-199, issn 0950-3536Article

High serum IL-2 levels are predictive of prolonged survival in multiple myelomaCIMINO, G; AVVISATI, G; MANDELLI, F et al.British journal of haematology. 1990, Vol 75, Num 3, pp 373-377, issn 0007-1048, 5 p.Article

High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaCIMINO, G; AVVISATI, G; AMADORI, S et al.Nouvelle revue française d'hématologie. 1989, Vol 31, Num 5, pp 329-332, issn 0029-4810Article